Ritonavir and Nirmatrelvir Tablet (Paxista Tablet)

Product Details

Strength Nirmatrelvir 150mg and Ritonavir 100mg Tablet
Packaging Type Strip
Brand Name Paxista
Manufacturer Azista
Composition Nirmatrelvir 150mg and Ritonavir 100mg Tablet
Dosage Nirmatrelvir 150mg and Ritonavir 100mg Tablet
Usages covid-19
Packaging Size 2 x 10 tablets & 1 x 10 Tablets
Tablets in a Strip 3


Paxista Tablet: A Promising Antiviral Therapy

Paxista Tablet, a composite pack of Nirmatrelvir 150 mg and Ritonavir 100 mg offers a glimmer of hope in the fight against COVID-19. Authorized by the FDA for emergency use, this medication is tailored for individuals aged 12 and above, recently diagnosed with coronavirus exhibiting mild to moderate symptoms for no more than five days, and not requiring hospitalization.


Composition and Mechanism

Comprising Nirmatrelvir, a potent SARS-CoV-2-3CL protease inhibitor, and Ritonavir, a pharmacokinetic enhancer, Paxista Tablets aim to halt viral replication and bolster the body’s defense against COVID-19. This synergistic combination ensures higher systemic concentrations of Nirmatrelvir, optimizing therapeutic efficacy.


Indications and Usage

Paxista Tablets specifically treat mild-to-moderate COVID-19 in adults and pediatric patients aged over 12 years and weighing more than 40 kg. It is recommended for individuals at high risk of disease progression, including hospitalization or death.


Administration and Dosage

Patients should adhere to the prescribed dosage and duration as directed by their healthcare provider. Paxista Tablets may be taken with or without food, preferably at a fixed time each day. It is essential to swallow the tablet whole, without crushing, chewing, or breaking it. In the event of a missed dose, patients should take it as soon as possible unless the next scheduled dose is almost due.


Safety and Side Effects

While generally well-tolerated, Paxista Tablets may cause mild side effects such as nausea, vomiting, diarrhea, headache, and rash. Patients experiencing persistent or severe adverse reactions should promptly consult their healthcare provider. Regular monitoring of liver function and blood counts may be advisable during treatment.



In the battle against COVID-19, Paxista Tablets offer a ray of hope, providing a targeted approach to combatting the virus. Also, reducing the risk of disease progression. With its unique combination of Nirmatrelvir and Ritonavir, Paxista stands at the forefront of antiviral therapy. To strive to improve outcomes and mitigate the impact of the pandemic.

Read More


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.